Search
Results: 5
31 P magnetic resonance spectroscopy in skeletal muscle
Martin Meyerspeer, Chris Boesch, Donnie Cameron, Monika Dezortová, Sean C Forbes, Arend Heerschap, Jeroen AL Jeneson, Hermien E Kan, Jane Kent, Gwenaël Layec, Jeanine J Prompers, Harmen Reyngoudt, Alison Sleigh, Ladislav Valkovič, Graham J Kemp, Experts' Working Group on 31P MR Spectroscopy of Skeletal Muscle
Apr 19, 2021
Skeletal muscle phosphorus-31 31 P MRS is the oldest MRS methodology to be applied to in vivo metabolic research. The technical requirements of 31 P MRS in skeletal muscle depend on the research question, and to assess those...
How in-store educational and entertaining events influence shopper satisfaction
While recent years have seen an increased use of educational and entertaining events within the store environment, little seems known about how consumers value such events. This study investigates how the staging of education...
How in-store educational and entertaining events influence shopper satisfaction
While recent years have seen an increased use of educational and entertaining events within the store environment, little seems known about how consumers value such events. This study investigates how the staging of education...
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.
Titia G Meijer, Luan Nguyen, Arne Van Hoeck, Anieta M Sieuwerts, Nicole S Verkaik, Marjolijn M Ladan, Kirsten Ruigrok-Ritstier, Carolien HM van Deurzen, Harmen JG van de Werken, Esther H Lips, Sabine C Linn, Yasin Memari, Helen Davies, Serena Nik-Zainal, Roland Kanaar, John WM Martens, Edwin Cuppen, Agnes Jager, Dik C van Gent
Jun 29, 2022
Germline BRCA1/2 mutation status is predictive for response to Poly-[ADP-Ribose]-Polymerase (PARP) inhibitors in breast cancer (BC) patients. However, non-germline BRCA1/2 mutated and homologous recombination repair deficient...
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.
Titia G Meijer, Luan Nguyen, Arne Van Hoeck, Anieta M Sieuwerts, Nicole S Verkaik, Marjolijn M Ladan, Kirsten Ruigrok-Ritstier, Carolien HM van Deurzen, Harmen JG van de Werken, Esther H Lips, Sabine C Linn, Yasin Memari, Helen Davies, Serena Nik-Zainal, Roland Kanaar, John WM Martens, Edwin Cuppen, Agnes Jager, Dik C van Gent
Jul 07, 2022
Germline BRCA1/2 mutation status is predictive for response to Poly-[ADP-Ribose]-Polymerase (PARP) inhibitors in breast cancer (BC) patients. However, non-germline BRCA1/2 mutated and homologous recombination repair deficient...